Tuberculosis: current issues in diagnosis and treatment. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Tuberculosis: current issues in diagnosis and treatment.

Br J Clin Pract. 1994 Sep-Oct;48(5):251-5. Unique Identifier : AIDSLINE MED/95001250
Polkey MI; Rees PJ; Department of Thoracic Medicine, Guy's Hospital, London.

Abstract: The incidence of tuberculosis began to decline in 1801, which was probably due to improving socioeconomic conditions (certainly not the efforts of the medical profession). Patients cannot be treated unless they are detected, which underlines the importance of notification and case finding. Full multiagent chemotherapy is necessary to give the best chance of permanent cure and to prevent the emergence of resistance; compliance with treatment is increased by making it readily accessible and increasing the degree of supervision. With the resurgence of interest in tuberculosis since the rising incidence of the late 1980s a review of the state of diagnosis and treatment is due. This one covers some areas of current interest: the role of vaccination, chemoprophylaxis, tuberculosis and HIV, new methods of diagnosis, drug resistance and alternative approaches to treatment.
Keywords: Antitubercular Agents/THERAPEUTIC USE AIDS-Related Opportunistic Infections/COMPLICATIONS BCG Vaccine/THERAPEUTIC USE Human *Tuberculosis/DIAGNOSIS/DRUG THERAPY/PREVENTION & CONTROL Tuberculosis, Multidrug-Resistant/DRUG THERAPY JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDantitubercularagents/therapeuticuseaids-relatedopportunisticinfections/complicationsbcgvaccine/therapeuticusehumanKWDtuberculosis/diagnosis/drugtherapy/prevention&controltuberculosis,multidrug-resistant/drugtherapyjournalarticlereviewreview,tutorial
950130
M9510829

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .